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Abstract
Background: Low-carbohydrate diets, due to their potent antihyperglycemic effect, are an
intuitively attractive approach to the management of obese patients with type 2 diabetes. We
previously reported that a 20% carbohydrate diet was significantly superior to a 55–60%
carbohydrate diet with regard to bodyweight and glycemic control in 2 groups of obese diabetes
patients observed closely over 6 months (intervention group, n = 16; controls, n = 15) and we
reported maintenance of these gains after 22 months. The present study documents the degree to
which these changes were preserved in the low-carbohydrate group after 44 months observation
time, without close follow-up. In addition, we assessed the performance of the two thirds of
control patients from the high-carbohydrate diet group that had changed to a low-carbohydrate
diet after the initial 6 month observation period. We report cardiovascular outcome for the low-
carbohydrate group as well as the control patients who did not change to a low-carbohydrate diet.
Method: Retrospective follow-up of previously studied subjects on a low carbohydrate diet.
Results: The mean bodyweight at the start of the initial study was 100.6 ± 14.7 kg. At six months
it was 89.2 ± 14.3 kg. From 6 to 22 months, mean bodyweight had increased by 2.7 ± 4.2 kg to an
average of 92.0 ± 14.0 kg. At 44 months average weight has increased from baseline g to 93.1 ±
14.5 kg. Of the sixteen patients, five have retained or reduced bodyweight since the 22 month point
and all but one have lower weight at 44 months than at start. The initial mean HbA1c was 8.0 ±
1.5%. After 6, 12 and 22 months, HbA1c was 6.1 ± 1.0%, 7.0 ± 1.3% and 6.9 ± 1.1% respectively.
After 44 months mean HbA1c is 6.8 ± 1.3%.
Of the 23 patients who have used a low-carbohydrate diet and for whom we have long-term data,
two have suffered a cardiovascular event while four of the six controls who never changed diet
have suffered several cardiovascular events.
Conclusion: Advice to obese patients with type 2 diabetes to follow a 20% carbohydrate diet with
some caloric restriction has lasting effects on bodyweight and glycemic control.
Background
Type 2 diabetes reflects a disturbance in the glucose-insu-
lin axis of metabolism and has insulin resistance as a
defining feature. As such, it is expected that carbohydrate
restriction would be the first line of attack and, in one
form or another, this was the primary approach before the
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some degree of carbohydrate reduction is a component of
much clinical treatment. Health agencies have generally
been reluctant to recommend carbohydrate restriction
although the recent American Diabetes Association guide-
lines recognize that such diets are at least as effective as
low fat diets for weight loss [2] and, while not recom-
mending low carbohydrate diets, recognizes that dietary
carbohydrate is the major factor in controlling blood glu-
cose. Short term studies [3-7] in fact, demonstrate dra-
matic improvements in glycemic control even in the
absence of weight loss [4].
Experience in our diabetes school showed that advice to
reduce fat and increase carbohydrates had a very limited
effect on long-term weight reduction in our obese diabe-
tes patients (unpublished data). We therefore decided to
test a different approach in an observational study with a
control group. We were interested in seeing the effect of
the diet in compliant patients, who could be expected to
adhere to it 3–6 months. This enabled us to measure the
actual effect of a carbohydrate-restricted diet with little
contamination of non-compliant subjects. To this end, all
patients were well-informed of the diet and its rationale
before they started. We considered a weight reduction of
10% of bodyweight to be of clinical significance.
We have previously reported the results of these dietary
changes over 6 months in 16 obese type 2 diabetes
patients with a control group. In 2003, the 16 were
advised to lower their carbohydrate intake to 20% of
energy. In the course of 6 months, they achieved signifi-
cantly better control of hyperglycemia and bodyweight
than a control group of similar patients (n = 15) advised
to follow the official guidelines where 55% carbohydrates
is recommended [5]. We have further reported that the
improvements were stable over 22 months [6].
We have now reviewed the clinical charts after 44 months
and present the data for the intervention group with
regard to glycemic control (HbA1c), bodyweight. Body
mass index (BMI = weight/m2) and lipids after 44 months.
We also report the results for 7 patients from the controls
who immediately switched to a 20% carbohydrate diet
and for whom long-term data is available.
Methods
The method has previously been described in detail [5,6].
In short, the 16 patients, all with BMI>30 kg/m2, free of
thyroid cardiac and renal disease – were advised to follow
a diet containing initially 1800 kcal for men and 1600
kcal for women. The proportions of carbohydrates, fat
and protein were 20%, 50% and 30% respectively. The
daily quantity of carbohydrates was 80–90 g. The recom-
mended carbohydrate consumption was limited to vege-
tables and salad. Instead of ordinary bread crisp/hard
bread was recommended, each slice containing 3.5 to 8 g
carbohydrates.
Excluded were starch-rich bread, pasta, potatoes, rice and
breakfast cereals. The patients were counselled not to eat
between meals. It was further recommended that they
walk 30 minutes a day and take a daily multivitamin sup-
plement containing extra calcium. There was an introduc-
tory meeting lasting most of one day. From day one
diabetic medication was reduced by 25–30% to avoid
hypoglycaemia. The patients monitored their own blood
glucose 4 times a day and were counselled by telephone
over the first few weeks for further reductions of medica-
tions.
The subjects were followed closely for 6 months with
group follow-ups every second week for the first 3 months
and once a months for the next 3 months.
The 15 controls were advised on a diet with about the
same caloric content at an introductory meeting., Propor-
tions of carbohydrates, fat and protein for this group were
55–60%, 25–30% and 15% respectively. In the normal
diabetes diet whole-grain products are recommended.
Generous helpings of vegetables and several servings of
fruits as snacks between meals are also recommended.
As a number of the controls attended our normal diabetes
educational course as introduction to the observation
period, the control group on average received about 50%
more attention – measured in hours – than the low-carbo-
hydrate group. The controls were then followed in the
same way as the low-carbohydrate group.
Seven of the 15 controls switched to a 20% carbohydrate
diet immediately after the 6 months follow-up period. For
those we have data 32–34 months after the change.
Three more controls sought information and attempted to
change diet later at various dates. The 5 remaining con-
trols have not attempted a change of diet despite receiving
additional information.
All the patients were known to us and visited the diabetes
nurse regularly after the initial period. The same scales
and laboratory were used for all measurements. The
present report is a review of clinical charts at about 44
months after the start of the study in 2003. Where a figure
is missing at 44 months we have taken the mean from the
two closest figures. Means are given with standard devia-
tions. T-test for dependent samples is used.Page 2 of 6
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Table 1 shows the measured parameters from start to 44
months. Triglycerides (TG) and HbA1c, both parameters
of adherence to the diet, were at their lowest after 3
months. The adherence in the group then became less
pronounced, again reflected in triglycerides and HbA1c.
Bodyweight
The mean reduction in bodyweight over the first six
months was 11.3 ± 4 kg (controls: 1.8 ± 3.8 kg). Ten
patients (62%) but none of the controls lost more than
10% of bodyweight.
Mean bodyweight increased from 6 to 22 months by 2.7
± 4.3 kg. The total mean increase from month 6 to 44 has
been 3.9 ± 5.6 kg. Five of the patients have maintained
bodyweight from 6 to 44 months or reduced it further (see
figure 1). However, five patients have increased mean
bodyweight by 10 kg. In 7 patients (43%) the bodyweight
is still 10% or more below their original weight.
HbA1c
The initial mean HbA1c in 2003 in the low-carbohydrate
group was 8.0 ± 1.5% (controls: 7.9 ± 1.5%). At the end
of the 6 months study period it was 6.6 ± 1.0% (controls:
7.3 ± 1.8%), and after 12 months it was 7.0 ± 1.3%. It has
since remained stable and is 6.8 ± 1.3% after 44 months.
The effect of carbohydrate lowering on blood glucose was
rapid. In the first week, mean fasting blood glucose
dropped from 11.7 ± 3.3 mmol/l to 7.0 ± 1.4 mmol/l
which necessitated corresponding reductions in medica-
tions.
Medications
An important feature of carbohydrate restriction is that
reduction and even elimination of antidiabetic medica-
tion normally is required in order to avoid hypoglycemia.
At the start of the study 15 of the 16 used metformin and
5 sulfonylurea (SU). Eleven of the patients were treated
with insulin at a mean daily dosage of 60 ± 33 IU.
All patients with SU reduced or discontinued it. Three
patients of 11 discontinued insulin and the average insu-
lin requirement of the last 8 persons was 18 ± 11 IU/day
after 6 months.
After 22 months 2 patients had resumed insulin treatment
following an increase of carbohydrates. The mean insulin
Table 1: Effect of diet on weight, BMI, HbA1c and fasting lipids. Sixteen obese patients with type 2 diabetes started at month 0 on a 
diet with the proportions: 20% carbohydrates, 30% protein and 50% fat. The figures shown are means before, 3, 6, 22 and 44 months 
after the dietary change.
Month 0 3 P* 6 P* 22 44 P*
Weight (kg) 100.6 ± 14.7 91.9 ± 14.7 <0.001 89.2 ± 14.3 <0.001 92.0 ± 14.0 93.1 ± 14.5 <0.001
BMI (kg/m2) 36.1 ± 4.2 33.0 ± 4.5 <0.001 32.0 ± 4.3 <0.001 32.9 ± 3.5 33.4 ± 3.9 <0.001
HbA1c (%) 8.0 ± 1.5 5.9 ± 0.7 <0.001 6.6 ± 1.0 <0.001 6.9 ± 1.1 6.8 ± 1.3 <0.001
Lipids(mmol/l)
Tot-Chol. 5.6 ± 1.2 5.8 ± 1.1 0.4 6.1 ± 1.1 0.06 5.7 ± 1.2 5.4 ± 1.0 0.8
HDL-Chol. 1.1 ± 0.2 1.2 ± 0.2 <0.002 1.3 ± 0.2 <0.001 1.3 ± 0.3 1.3 ± 0.2 <0.001
§Triglycerides 1.4 (1;1.8) 1.2(0.8;1,4) 0.01 1.4(0.9;1.7) 0.4 1.4(1.2;1.9) 1.4(1.2–2) 0.9
Chol/HDL 5.4 ± 1.5 5.0 ± 1.5 0.02 5.0 ± 1.7 0.07 4.6 ± 1.6 4.1 ± 0.9 <0.001
§TG/HDL 1.4(0.9;1.7) 1.0(0.6;1.2) 0.003 1.0(0.7;1.5) 0.03 1.3(0.8;1.5) 1.1(0.9;1.7) 0.7
§given as medians with 25 and 75 percentiles. * p values are for differences from baseline.
Individual changes in bodyweight in 16 obese patients with type 2 diabetesFigure 1
Individual changes in bodyweight in 16 obese patients 
with type 2 diabetes. The patients at start changed from a 
high-carbohydrate diet to a diet consisting of 20% carbohy-
drates, 30% protein and 50% fat. The dotted red line is the 
mean weight.Page 3 of 6
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21 IU/day. After 44 months the same 10 persons are still
using insulin. The mean requirement is 41 ± 34 IU/day.
The cross-over of the 7 controls
After the initial 6 months study period 7 of the 15 controls
switched to a 20% carbohydrate diet. They had been fol-
lowed closely during the 6 months on a low-fat, high-car-
bohydrate diet, and then – separated by a gap of 2
months-followed again with regular meetings for 6
months on a 20% carbohydrate diet. During this latter
period, they achieved excellent results with regard to bod-
yweight and glycemic control as has been described previ-
ously [6]. However, both mean HbA1c and weight have
increased over the last 2 years.
Table 2 shows mean status for the controls who have
switched to a carbohydrate-restricted diet. Three more
controls have attempted a change of diet at later dates
with varying success.
Diabetes free
Of the total of 10 controls, who have switched diet, 2 per-
sons after a weight reduction of 20 kg each are free of all
signs of diabetes after 3 and 2 years respectively i.e. HbA1c
below 5.0%, fasting blood glucose below 5.0 mmol/l and
free of any blood glucose lowering medication.
Cardiovascular disease
We have examined medical charts for episodes of cardio-
vascular disease beginning 3 months after the initiation of
the diet therapy.
Among the 16 patients in the low-carbohydrate diet group
(41 months observations time) and among the 7 controls
that changed from the high-carbohydrate diet to the
opposite (33 months observations time) – totalling 23
patients – 2 patients have suffered cardiovascular disease,
stroke and heart failure respectively (8.5%. 95% confi-
dence interval (CI 95%): 1.0–28.0). One patient without
known cardiac disease has died suddenly. Autopsy
showed no sign of coronary thrombosis, myocardial inf-
arction or stroke. The cause of death unknown but
assumed to be general atherosclerosis.
As for the 3 controls who switched diet at later dates, there
has been no occurrence of cardiovascular disease.
Four patients (80%. CI 95%: 28.3–99.5) among the 5
controls that never attempted any change of diet have suf-
fered several heart infarctions followed by heart failure.
Two of them have died from their heart disease (p = 0.025.
Fischer Exact).
Discussion
A summary of the implications of the current work:
1. This year, for the first time, the ADA accepted the value
of carbohydrate-restricted diet for weight loss. The text of
their guidelines, however, continues previous guidelines
in finding fault with such diets and, in fact, does not cite
most of the recent publications supporting their use [2].
Other health agencies have similarly insisted on low fat
approaches. There is reason to believe that these guide-
lines are not followed in practice. A perusal of internet
diabetes sites suggests that the major dietary emphasis is
on carbohydrate control.
2. The major barrier to official acceptance is the stated lack
of long term trials although it has never been stated what
the features of successes in short term trials suggest that
they would not be maintained.
3. The work presented here suggests the importance of
funding large scale long term trials as well as the benefits
and limited risk in using low carbohydrate diets now.
4. Several studies have shown that low fat diets can be suc-
cessful but overall, it would be difficult to say they are
inherently reliable.
5. In the studies reported here, patients in the two groups
had, despite all possible support, failed in achieving an
acceptable control of bodyweight and hyperglycemia on
traditional low fat diets.
8. An important issue is the fact that some patients do
become completely free of disease as soon as they are pre-
sented with a low-carbohydrate option. It is unknown
what factors make these persons succeed now despite
complete failure in the past.
In the low-carbohydrate group bodyweight and HbA1c is
still significantly lower than before start. The bodyweight
of 7 patients (43%) is still 10% below the initial weight,
the original goal of the study. The success rate almost 4
Table 2: Mean weight and HbA1c for the low-fat, high-CHO 
group (n = 7) at start and after 6–8 months on a high-CHO diet 
(months 0 and 8), and after cross-over to low-carbohydrate at 
months 15, 22 and 44.
Months Weight (kg) HbA1c (%)
0. (start High-CHO) 99.7 ± 17.7 7.1 ± 1.2
8 (start Low-CHO) 96.5 ± 19.4 6.6 ± 0.7
15 89.1 ± 16.0 5.7 ± 0.8
22 91.9 ± 17.0 6.0 ± 1.0
44 93.7 ± 17.3 6.5 ± 0.8Page 4 of 6
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group.
Five of 16 patients in the intervention group have had sta-
ble bodyweight 38 months after the conclusion of the 6
months study period without any special follow-up.
Weight increase has been preceded by an increased intake
of carbohydrates in those cases where it has occurred. It is
clear that the high-carbohydrate diet followed before the
study has been an important, probably the central, con-
tributing cause of their condition.
One rationale for a low-carbohydrate diet is the experi-
mentally observed reduction in hunger [8] Patients gener-
ally reported that hunger was absent on the intervention
diet and only after increasing dietary carbohydrates did it
return.
The intensity of hunger has been reported to be positively
correlated to the proportion of carbohydrates in obese
men over a 4 week period [9].
We believe that the close follow-up was important.
Patients had many questions at each meeting and con-
cerns about the diet that might have hindered adherence
were cleared up. In additions individual patients received
support from the group.
There is now little evidence for the claim that a fat-reduced
diet for weight reduction has any particular value beyond
caloric counting [10]. On the other hand, six randomised
studies have shown that carbohydrate restriction with ad-
libitum energy intake confers a significant benefit with
regard to weight loss in obese persons [11-16]. The current
study is consistent with these reports and suggests that
high-starch, high-carbohydrate diets excessively stimulate
appetite and disturb energy balance in patients with the
metabolic syndrome and type 2 diabetes [3]. A reduction
of carbohydrates normalises the balance, reduces insulin
concentrations and favours utilization of stored fat as fuel
as well as significantly reducing insulin resistance [3].
Considering the solid evidence for the negative effect of
hyperglycemia on diabetes complications as well as cardi-
ovascular disease the present high-carbohydrate dietary
advice resulting in unnecessary hyperglycemia and insulin
resistance seems difficult to support [17-19] and for dia-
betes patients, current dietary recommendations seem to
be a major part of their problem rather than being part of
the solution. Carbohydrate restriction, however, reverses
or neutralises all aspects of the metabolic syndrome
[20,21].
Summary: A reduced carbohydrate diet is effective in
motivated patients and can be recommended for over-
weight patients with type 2 diabetes. There has been no
sign of a negative cardiovascular effect.
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